tiprankstipranks
Trending News
More News >
Argenx Se (ARGX)
NASDAQ:ARGX
US Market

Argenx Se (ARGX) Stock Forecast & Price Target

Compare
637 Followers
See the Price Targets and Ratings of:

ARGX Analyst Ratings

Strong Buy
23Ratings
Strong Buy
21 Buy
2 Hold
0 Sell
Based on 23 analysts giving stock ratings to
Argenx
Se
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$764.81
▲(37.76%Upside)
Based on 23 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $764.81 with a high forecast of $1,065.00 and a low forecast of $620.00. The average price target represents a 37.76% change from the last price of $555.19.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"433":"$433","1066":"$1,066","591.25":"$591.3","749.5":"$749.5","907.75":"$907.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1065,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.06K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":764.81,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$764.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":620,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$620.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[433,591.25,749.5,907.75,1066],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,542.47,582.6646153846154,622.8592307692307,663.0538461538462,703.2484615384616,743.4430769230769,783.6376923076923,823.8323076923077,864.0269230769231,904.2215384615384,944.4161538461539,984.6107692307692,1024.8053846153846,{"y":1065,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,542.47,559.573076923077,576.6761538461539,593.7792307692308,610.8823076923077,627.9853846153846,645.0884615384615,662.1915384615385,679.2946153846153,696.3976923076923,713.5007692307692,730.6038461538461,747.706923076923,{"y":764.81,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,542.47,548.4338461538462,554.3976923076923,560.3615384615384,566.3253846153847,572.2892307692308,578.253076923077,584.2169230769231,590.1807692307692,596.1446153846153,602.1084615384616,608.0723076923077,614.0361538461539,{"y":620,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":434.22,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 69,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":516.18,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":517.32,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":547.28,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":595.58,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":617.49,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":615,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":655.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":624.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,065Average Price Target$764.81Lowest Price Target$620.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARGX
TipRanks AITipRanks
Not Ranked
TipRanks
$631
Hold
13.65%
Upside
Downgraded
06/14/25
Argenx Se's strong financial performance, highlighted by impressive revenue growth and a robust earnings call, boosts its overall score. However, mixed technical indicators and valuation challenges slightly temper the outlook.
Wells Fargo Analyst forecast on ARGX
Derek ArchilaWells Fargo
Wells Fargo
$400$1,000
Buy
80.12%
Upside
Reiterated
07/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (NASDAQ: SGHT) and Argenx Se (NASDAQ: ARGX)
Goldman Sachs Analyst forecast on ARGX
Richard FeltonGoldman Sachs
Goldman Sachs
$832$835
Buy
50.40%
Upside
Reiterated
07/04/25
Goldman Sachs Remains a Buy on Argenx Se (ARGX)
Morgan Stanley Analyst forecast on ARGX
Sean LaamanMorgan Stanley
Morgan Stanley
$700
Buy
26.08%
Upside
Initiated
07/02/25
Argenx's Strong Growth Prospects and Strategic Positioning Drive Buy Rating
H.C. Wainwright Analyst forecast on ARGX
Douglas TsaoH.C. Wainwright
H.C. Wainwright
$720
Buy
29.69%
Upside
Reiterated
07/01/25
Argenx Se's Advancements in Neuromuscular Treatment Pipeline Drive Buy Rating
Leerink Partners Analyst forecast on ARGX
Thomas SmithLeerink Partners
Leerink Partners
Buy
Reiterated
06/30/25
Argenx Se: Overcoming Volatility with Promising Pipeline and Strong Immunology Position
TD Cowen Analyst forecast on ARGX
Yaron WerberTD Cowen
TD Cowen
$761
Buy
37.07%
Upside
Reiterated
06/30/25
We continue to expect solid Q2 and reiterate Buy.
William Blair Analyst forecast on ARGX
Myles MinterWilliam Blair
William Blair
Buy
Reiterated
06/30/25
Argenx Se: Buy Rating Amidst Volatility and Proactive Risk Management
Bank of America Securities Analyst forecast on ARGX
Tazeen AhmadBank of America Securities
Bank of America Securities
$804
Buy
44.82%
Upside
Reiterated
06/30/25
Argenx weakness presents 'attractive opportunity,' says BofAArgenx weakness presents 'attractive opportunity,' says BofA
Citi
$803
Buy
44.64%
Upside
Reiterated
06/30/25
Citi Keeps Their Buy Rating on Argenx Se (ARGX)
Wedbush
$715
Buy
28.78%
Upside
Reiterated
06/24/25
Wedbush Reaffirms Their Buy Rating on Argenx Se (ARGX)
Evercore ISI
$750
Buy
35.09%
Upside
Reiterated
06/24/25
Evercore ISI Keeps Their Buy Rating on Argenx Se (ARGX)
AI Firm
$639$631
Hold
13.65%
Upside
Downgraded
06/14/25
Truist Financial Analyst forecast on ARGX
Joon LeeTruist Financial
Truist Financial
Buy
Reiterated
06/13/25
Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFAStifel Nicolaus
Stifel Nicolaus
$780
Buy
40.49%
Upside
Reiterated
05/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vor Biopharma (NASDAQ: VOR), Clearside Biomedical (NASDAQ: CLSD) and Argenx Se (NASDAQ: ARGX)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ARGX
TipRanks AITipRanks
Not Ranked
TipRanks
$631
Hold
13.65%
Upside
Downgraded
06/14/25
Argenx Se's strong financial performance, highlighted by impressive revenue growth and a robust earnings call, boosts its overall score. However, mixed technical indicators and valuation challenges slightly temper the outlook.
Wells Fargo Analyst forecast on ARGX
Derek ArchilaWells Fargo
Wells Fargo
$400$1,000
Buy
80.12%
Upside
Reiterated
07/08/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (NASDAQ: SGHT) and Argenx Se (NASDAQ: ARGX)
Goldman Sachs Analyst forecast on ARGX
Richard FeltonGoldman Sachs
Goldman Sachs
$832$835
Buy
50.40%
Upside
Reiterated
07/04/25
Goldman Sachs Remains a Buy on Argenx Se (ARGX)
Morgan Stanley Analyst forecast on ARGX
Sean LaamanMorgan Stanley
Morgan Stanley
$700
Buy
26.08%
Upside
Initiated
07/02/25
Argenx's Strong Growth Prospects and Strategic Positioning Drive Buy Rating
H.C. Wainwright Analyst forecast on ARGX
Douglas TsaoH.C. Wainwright
H.C. Wainwright
$720
Buy
29.69%
Upside
Reiterated
07/01/25
Argenx Se's Advancements in Neuromuscular Treatment Pipeline Drive Buy Rating
Leerink Partners Analyst forecast on ARGX
Thomas SmithLeerink Partners
Leerink Partners
Buy
Reiterated
06/30/25
Argenx Se: Overcoming Volatility with Promising Pipeline and Strong Immunology Position
TD Cowen Analyst forecast on ARGX
Yaron WerberTD Cowen
TD Cowen
$761
Buy
37.07%
Upside
Reiterated
06/30/25
We continue to expect solid Q2 and reiterate Buy.
William Blair Analyst forecast on ARGX
Myles MinterWilliam Blair
William Blair
Buy
Reiterated
06/30/25
Argenx Se: Buy Rating Amidst Volatility and Proactive Risk Management
Bank of America Securities Analyst forecast on ARGX
Tazeen AhmadBank of America Securities
Bank of America Securities
$804
Buy
44.82%
Upside
Reiterated
06/30/25
Argenx weakness presents 'attractive opportunity,' says BofAArgenx weakness presents 'attractive opportunity,' says BofA
Citi
$803
Buy
44.64%
Upside
Reiterated
06/30/25
Citi Keeps Their Buy Rating on Argenx Se (ARGX)
Wedbush
$715
Buy
28.78%
Upside
Reiterated
06/24/25
Wedbush Reaffirms Their Buy Rating on Argenx Se (ARGX)
Evercore ISI
$750
Buy
35.09%
Upside
Reiterated
06/24/25
Evercore ISI Keeps Their Buy Rating on Argenx Se (ARGX)
AI Firm
$639$631
Hold
13.65%
Upside
Downgraded
06/14/25
Truist Financial Analyst forecast on ARGX
Joon LeeTruist Financial
Truist Financial
Buy
Reiterated
06/13/25
Truist Financial Sticks to Their Buy Rating for Argenx Se (ARGX)
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFAStifel Nicolaus
Stifel Nicolaus
$780
Buy
40.49%
Upside
Reiterated
05/15/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Vor Biopharma (NASDAQ: VOR), Clearside Biomedical (NASDAQ: CLSD) and Argenx Se (NASDAQ: ARGX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

1 Month
xxx
Success Rate
13/18 ratings generated profit
72%
Average Return
+6.91%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 72.22% of your transactions generating a profit, with an average return of +6.91% per trade.
3 Months
xxx
Success Rate
12/18 ratings generated profit
67%
Average Return
+9.05%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.05% per trade.
1 Year
Joel BeattyRobert W. Baird
Success Rate
18/20 ratings generated profit
90%
Average Return
+25.54%
upgraded a buy rating 2 months ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 90.00% of your transactions generating a profit, with an average return of +25.54% per trade.
2 Years
xxx
Success Rate
19/20 ratings generated profit
95%
Average Return
+33.59%
upgraded a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 95.00% of your transactions generating a profit, with an average return of +33.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
1
2
4
3
4
Buy
34
39
46
53
39
Hold
3
3
3
1
0
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
39
44
53
57
43
In the current month, ARGX has received 43 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 764.81.
Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $3.02 with a range of $2.19 to $3.91. The previous quarter’s EPS was $2.58. ARGX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.
Next quarter’s earnings estimate for ARGX is $3.02 with a range of $2.19 to $3.91. The previous quarter’s EPS was $2.58. ARGX beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.10% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $874.92M with a range of $826.20M to $935.80M. The previous quarter’s sales results were $790.05M. ARGX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.
Next quarter’s sales forecast for ARGX is $874.92M with a range of $826.20M to $935.80M. The previous quarter’s sales results were $790.05M. ARGX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ARGX has Outperformed its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Argenx Se’s 12-month average price target is 764.81.
    What is ARGX’s upside potential, based on the analysts’ average price target?
    Argenx Se has 37.76% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARGX a Buy, Sell or Hold?
          Argenx Se has a consensus rating of Strong Buy which is based on 21 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Argenx Se’s price target?
            The average price target for Argenx Se is 764.81. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,065.00 ,the lowest forecast is $620.00. The average price target represents 37.76% Increase from the current price of $555.19.
              What do analysts say about Argenx Se?
              Argenx Se’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
                How can I buy shares of ARGX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis